Ointment to Prevent Scar After Thyroidectomy

Last updated: April 19, 2023
Sponsor: Innovo Therapeutics, Inc.
Overall Status: Active - Recruiting

Phase

2

Condition

N/A

Treatment

INV-001

Clinical Study ID

NCT05838833
INV001-01
  • Ages > 19
  • All Genders

Study Summary

The goal of this study is to evaluate the efficacy and Safety of INV-001 administration for the prevention of scar after thyroidectomy.

Participants will be asked to apply ointment on their scar for 12 weeks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient who got thyroidectomy due to Thyroid cancer
  • has scar longer than 3 cm

Exclusion

Exclusion Criteria:

  • have history about Keloid or Hypertrophic scar
  • have infection on surgical site

Study Design

Total Participants: 75
Treatment Group(s): 1
Primary Treatment: INV-001
Phase: 2
Study Start date:
February 14, 2023
Estimated Completion Date:
June 30, 2024

Study Description

to evaluate the efficacy

-investigator check POSAS and VSS

Connect with a study center

  • Innovo Therapeutics, Inc.

    Seoul,
    Korea, Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.